Research suggests that miRNA and cytokines could be able to predict the likelihood of acute rejection and organ dysfunction following kidney transplants.
Weiping Shao discusses biomarkers, immunogenicity and the work he contributes to at Regeneron Pharmaceuticals (NY,USA).
Researchers evaluate the use of inflammatory molecules as potential biomarkers for amyotrophic lateral sclerosis
Levels of inflammatory molecules could be utilised as diagnostic markers for amyotrophic lateral sclerosis.
Blood samples from patients affected by an autoimmune disease demonstrate a significant increase in a specific type of immune cells, called T follicular regulatory cells.
A perspective on the challenges and issues in developing biomarkers for human allergic risk assessments
In this commentary the authors explore developing biomarkers for allergic risk assessments and the challenges and issues involved.
Novel preoperative biomarkers could be strong prognostic indicators in pancreatic ductal adenocarcinomas
Could two novel biomarkers change the standard in care and treatment of pancreatic ductal adenocarcinomas? Recent research suggests a change in preoperative prognoses and a step forward in personalized medicine.
Researchers have identified new biomarkers that could aid stage-specific diagnosis of Alzheimer’s, leading to advancements in treatment.
Findings, published in The Lancet, Diabetes & Endocrinology, record the results from a large collaborative…
Circulating eosinophils could potentially be utilized as biomarkers for chronic obstructive pulmonary disease.
Feedback from the EBF – Focus Workshop: bringing assay validation and analysis of biomarkers into practice
This conference report, from the European Bioanalysis Forum Focus Workshop, Lisbon, Portugal, 9–10 June 2016, summarizes the essence from the conference discussions and from the proposals or conclusions made by all delegates on how to increase the necessary connectivity of the stakeholders involved in the bioanalysis of biomarkers.